ORIGINAL STUDIES |
Zyryanov S.K., Butranova O.I.
Effectiveness of including azoximer bromide in the standard management of ICU patients with severe COVID-19
|
7-17 |
Karoli N.A., Borodkin A.V., Rebrov A.P.
Risk factors for the development of adverse outcomes in patients with chronic obstructive pulmonary disease
|
18-25 |
Ovchinnikov Yu.V., Mostovoy L.V., Zaitsev A.A.
New criteria for long-term CPAP therapy adherence in obstructive sleep apnea syndrome and arterial hypertension patients
|
26-38 |
Kobzeva N.D., Martynov A.I., Terentiev V.P.
Prediction of the risk of myocardial infarction development in patients with peripheral atherosclerosis in the long term
|
39-46 |
Bulatova I.A., Shevlyukova T.P., Shchekotova A.P., Paducheva S.V., Martynov A.I.
Polymorphism of cytokine genes in patients with liver cirrhosis
|
47-52 |
REVIEWS |
Babak S.L., Gorbunova M.V., Goruleva E.I., Malyavin A.G.
Nebulized budesonide in asthma exacerbations: rules of therapy in the COVID-19 era
|
53-61 |
Starodubtseva I.A., Lesina V.S., Kostina N.E., Venderevskaya K.V.
Bronchial asthma and cardiovascular comorbidity: interconnections and approaches to therapy
|
62-66 |
Alieva A.M., Reznik E.V., Teplova N.V., Totolyan G.G., Gasanova E.T., Kalova M.R., Sabanchieva E.E., Nikitin I.G.
JDP2 – a new promising biological marker in cardiovascular pathology
|
67-73 |
LECTURE |
Bolieva L.Z., Malyavin A.G., Ovsyannikova A.I.
Invasive fungal infections in patients with COVID-19
|
74-80 |
Malyavin A.G., Kostina N.E., Efremova O.Yu., Levina O.A., Evseev A.K., Shabanov A.K.
Hyperbaric oxygenation in the complex for long-COVID-infection rehabilitation measures
|
81-85 |
Guideline for practitioners |
Zaitsev A.A., Leshchenko I.V., Malyavin A.G.
Acute bronchitis – project of clinical guidelines
|
86-95 |
Resolution of the Expert council «Dysbiosis. immediate and long-term consequences of microbiome disturbances and options for their correction with the help of probiotics» (from February 19, 2022)
|
96-106 |
Resolution of the Expert council «Herbal medicines with proven clinical efficacy in physician›s clinical practice»
|
107-118 |
Resolution of the consensus of Russian Federation experts on the diagnosis and treatment of osteoarthritis for primary care physicians
|
119-128 |
ACTUAL ISSUES OF PHARMACOTHERAPY |
Lazebnik L.B.
Increasing the efficiency of eradication anti-Helicobacter therapy by combined pharmaceuticals set use
|
129-135 |
Malyavin A.G., Gorelov A.V., Antonova E.A., Pobedinskaya T.A., Globenko А.А., Kapashin A.V., Bagaeva M.I.
Efficacy and safety evaluation of Ingavirin® as COVID-19 antiviral therapy: clinical trial
|
136-144 |
Tarzimanova A.I.
The significance of non-alcoholic fatty liver disease in atrial fibrillation development: view of cardiologist
|
145-150 |
Shishkova V.N.
Aspects of post-COVID asthenia symptoms correction
|
151-156 |
Activities of RNMOT |
20th European Congress of Internal Medicine: at the front of the healthcare system (9–11 June 2022, Malaga, Spain)
|
157-158 |
Report on the Vth Therapeutic Forum «Multidisciplinary patient» and the Vth Conference of Young Therapists (26–27 May 2022, Saint Petersburg)
|
159-161 |
Digest of interregional scientific and practical events under the aegis or with the participation of RSMSIM (May–June 2022)
|
162-168 |